• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

药品伦理：揭露药品各领域的不道德行为和腐败现象对于改善全球公共卫生和拯救患者生命至关重要。

Ethics in Medicines: Exposing Unethical Practices and Corruption in All Sectors of Medicines Is Essential for Improving Global Public Health and Saving Patients' Lives.

作者信息

Kontoghiorghes George J

机构信息

Postgraduate Research Institute of Science, Technology, Environment and Medicine, Limassol 3021, Cyprus.

出版信息

Medicines (Basel). 2021 Sep 14;8(9):54. doi: 10.3390/medicines8090054.

DOI:10.3390/medicines8090054
PMID:34564096
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8466734/
Abstract

While great strides have been made in science and medicine ensuring better living standards and health care for most human beings, many issues still remain, which are responsible for an increase in mortality and morbidity rates of millions of people worldwide, despite that in most cases the causes are preventable [...].

摘要

尽管科学和医学已经取得了巨大进步，确保了大多数人的生活水平和医疗保健得到改善，但许多问题仍然存在，这些问题导致全球数百万人的死亡率和发病率上升，尽管在大多数情况下这些原因是可以预防的[……]

相似文献

1
Ethics in Medicines: Exposing Unethical Practices and Corruption in All Sectors of Medicines Is Essential for Improving Global Public Health and Saving Patients' Lives.药品伦理：揭露药品各领域的不道德行为和腐败现象对于改善全球公共卫生和拯救患者生命至关重要。
Medicines (Basel). 2021 Sep 14;8(9):54. doi: 10.3390/medicines8090054.
2
An interdisciplinary review of digital technologies to facilitate anti-corruption, transparency and accountability in medicines procurement.关于促进药品采购中的反腐败、透明度和问责制的数字技术的跨学科综述。
Glob Health Action. 2020;13(sup1):1695241. doi: 10.1080/16549716.2019.1695241.
3
Tackling corruption in the pharmaceutical systems worldwide with courage and conviction.以勇气和信念应对全球制药系统中的腐败问题。
Clin Pharmacol Ther. 2007 Mar;81(3):445-9. doi: 10.1038/sj.clpt.6100074. Epub 2007 Jan 24.
4
Problems associated with substandard and counterfeit drugs in developing countries: a review article on global implications of counterfeit drugs in the era of antiretroviral (ARVs) drugs in a free market economy.发展中国家与不合格药品和假药相关的问题：一篇关于自由市场经济中抗逆转录病毒药物时代假药全球影响的综述文章。
East Afr J Public Health. 2008 Dec;5(3):205-10. doi: 10.4314/eajph.v5i3.39004.
5
The 2023 Latin America report of the Countdown on health and climate change: the imperative for health-centred climate-resilient development.《2023年健康与气候变化倒计时拉丁美洲报告：以健康为中心的气候适应型发展的必要性》
Lancet Reg Health Am. 2024 Apr 23;33:100746. doi: 10.1016/j.lana.2024.100746. eCollection 2024 May.
6
Corruption in healthcare and medicine: why should physicians and bioethicists care and what should they do?医疗保健与医学领域的腐败现象：医生和生物伦理学家为何应予以关注，又该如何应对？
Indian J Med Ethics. 2013 Jul-Sep;10(3):153-9. doi: 10.20529/IJME.2013.049.
7
Assessing national governance of medicine promotion: an exploratory study in Ghana to trial a structured set of indicators.评估药品促销的国家治理：在加纳进行的一项探索性研究，以试用一套结构化指标。
J Pharm Policy Pract. 2019 Sep 4;12:26. doi: 10.1186/s40545-019-0187-9. eCollection 2019.
8
Access to affordable medicines after health reform: evidence from two cross-sectional surveys in Shaanxi Province, western China.医改后获得平价药品的机会：来自中国西部陕西省的两项横断面调查证据。
Lancet Glob Health. 2013 Oct;1(4):e227-37. doi: 10.1016/S2214-109X(13)70072-X. Epub 2013 Sep 24.
9
Availability and affordability of priority life-saving medicines for under-five children in health facilities of Tigray region, northern Ethiopia.提格雷地区（埃塞俄比亚北部）卫生机构中 5 岁以下儿童优先救命药品的可及性和可负担性。
BMC Pregnancy Childbirth. 2018 Nov 29;18(1):464. doi: 10.1186/s12884-018-2109-2.
10
Pharmaceutical companies and global lack of access to medicines: strengthening accountability under the right to health.制药公司与全球药物获取不足：在健康权下加强问责制。
J Law Med Ethics. 2012 Summer;40(2):234-50. doi: 10.1111/j.1748-720X.2012.00661.x.

引用本文的文献

1
Ethical Frameworks and Global Health: A Narrative Review of the "Leave No One Behind" Principle.伦理框架与全球健康：“不让任何人掉队”原则的叙事性综述。
Inquiry. 2024 Jan-Dec;61:469580241288346. doi: 10.1177/00469580241288346.
2
Post COVID-19 Reflections and Questions: How Prepared Are We for the Next Pandemic?新冠疫情后的反思与问题：我们对下一次大流行做好准备了吗？
Int J Mol Sci. 2024 Jan 10;25(2):859. doi: 10.3390/ijms25020859.
3
Pharmaceutical Payments to Japanese Board-Certified Infectious Disease Specialists: A Four-Year Retrospective Analysis of Payments from 92 Pharmaceutical Companies between 2016 and 2019.医药企业向日本传染病专家支付情况：92 家药企 2016-2019 年四年间支付情况回顾性分析。
Int J Environ Res Public Health. 2022 Jun 16;19(12):7417. doi: 10.3390/ijerph19127417.
4
Questioning Established Theories and Treatment Methods Related to Iron and Other Metal Metabolic Changes, Affecting All Major Diseases and Billions of Patients.质疑与铁及其他金属代谢变化相关的既定理论和治疗方法，影响所有主要疾病和数十亿患者。
Int J Mol Sci. 2022 Jan 25;23(3):1364. doi: 10.3390/ijms23031364.

本文引用的文献

1
Differences between the European Union and United States of America in Drug Regulatory Affairs Affect Global Patient Safety Standards and Public Health Awareness: The Case of Deferasirox and Other Iron Chelating Drugs.欧盟与美国在药品监管事务上的差异影响全球患者安全标准和公众健康意识：以地拉罗司及其他铁螯合剂药物为例
Medicines (Basel). 2021 Jul 7;8(7):36. doi: 10.3390/medicines8070036.
2
Conventional and Unconventional Approaches for Innovative Drug Treatments in COVID-19: Looking Outside of Plato's Cave.新冠病毒药物治疗的常规与非常规方法：走出柏拉图洞穴。
Int J Mol Sci. 2021 Jul 5;22(13):7208. doi: 10.3390/ijms22137208.
3
Access and Unmet Needs of Orphan Drugs in 194 Countries and 6 Areas: A Global Policy Review With Content Analysis.194 个国家和 6 个地区的孤儿药可及性和未满足需求：一项基于内容分析的全球政策回顾。
Value Health. 2020 Dec;23(12):1580-1591. doi: 10.1016/j.jval.2020.06.020. Epub 2020 Oct 31.
4
Exploring anti-corruption, transparency, and accountability in the World Health Organization, the United Nations Development Programme, the World Bank Group, and the Global Fund to Fight AIDS, Tuberculosis and Malaria.探索世界卫生组织、联合国开发计划署、世界银行集团和全球抗击艾滋病、结核病和疟疾基金在反腐败、透明度和问责制方面的情况。
Global Health. 2020 Oct 20;16(1):101. doi: 10.1186/s12992-020-00629-5.
5
The COVID-19 Pandemic: Does Our Early Life Environment, Life Trajectory and Socioeconomic Status Determine Disease Susceptibility and Severity?COVID-19 大流行：我们的早期生活环境、生活轨迹和社会经济地位是否决定了疾病易感性和严重程度？
Int J Mol Sci. 2020 Jul 19;21(14):5094. doi: 10.3390/ijms21145094.
6
Anti-corruption, transparency and accountability in health: concepts, frameworks, and approaches.医疗卫生领域的反腐败、透明度与问责制：概念、框架及方法
Glob Health Action. 2020;13(sup1):1694744. doi: 10.1080/16549716.2019.1694744.
7
Corruption in global health: the open secret.全球卫生领域的腐败：公开的秘密。
Lancet. 2019 Dec 7;394(10214):2119-2124. doi: 10.1016/S0140-6736(19)32527-9. Epub 2019 Nov 27.
8
The sustainable development goals as a framework to combat health-sector corruption.可持续发展目标作为打击卫生部门腐败的框架。
Bull World Health Organ. 2018 Sep 1;96(9):634-643. doi: 10.2471/BLT.18.209502. Epub 2018 Jun 4.
9
Patent rulings raise hope for cheap cancer drugs in India.专利裁决为印度廉价抗癌药物带来希望。
Lancet Oncol. 2013 Oct;14(11):e441. doi: 10.1016/S1470-2045(13)70395-4. Epub 2013 Aug 23.
10
Multi-Criteria Decision Analysis for Assessment and Appraisal of Orphan Drugs.用于罕见病药物评估与评价的多标准决策分析
Front Public Health. 2016 Sep 30;4:214. doi: 10.3389/fpubh.2016.00214. eCollection 2016.